According to the Zhitong Finance APP, Hualan Vaccine (301207.SZ) released the third quarter report of 2024. The company's revenue for the first three quarters was 0.957 billion yuan, a decrease of 44.28% year-on-year. The net income attributable to shareholders of the listed company was 0.267 billion yuan, a decrease of 57.54% year-on-year. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.196 billion yuan, a decrease of 64.65% year-on-year. The basic earnings per share is 0.4463 yuan.